| abstract |
Heterocyclic-substituted tricyclics of the formula n nor a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein n represents an optional double bond, the dotted line is optionally a bond or no bond, resulting in a double bond or a single bond, as permitted by the valency requirement and wherein A n , E n , M n , U n , G n , J n , K n , R 9 , R 10 , R 11 , R 32 , R 33 , B and Het are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed. |